Concepedia

Roger A. Fujimoto

RA

11

Publications

656

Citations

11

H-Index

1980

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Roger A. Fujimoto is an author at Novartis (Switzerland) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1980–2014

11

Publications

11

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2

Ronald E. Esser, Carol Berry, Zhengming Du et al. · British Journal of Pharmacology · 2005 · 123 citations · Full text

, , +17

Multiple cyclophilins involved in different cellular pathways mediate HCV replication

L. Alex Gaither, Jason Borawski, Leah J. Anderson et al. · Virology · 2009 · 84 citations

, , +6

Total synthesis of (.+-.)-gephyrotoxin

Roger A. Fujimoto, Yoshito Kishi, John F. Blount · Journal of the American Chemical Society · 1980 · 82 citations

, , +18

Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase‐2

Jonathan N. King, Janet Dawson, Ronald E. Esser et al. · Journal of Veterinary Pharmacology and Therapeutics · 2009 · 76 citations · Full text

, , +16

Mechanism of Resistance of Hepatitis C Virus Replicons to Structurally Distinct Cyclophilin Inhibitors

Xiaoling Puyang, Danielle L. Poulin, Joanna E. Mathy et al. · Antimicrobial Agents and Chemotherapy · 2010 · 73 citations · Full text

, , +19

Rows per page

1–5 of 11